The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-On the radar: no game changer

Mon, 02nd Nov 2020 07:38

Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com

ON THE RADAR: NO GAME CHANGER (0730 GMT)

Futures are still showing no clear direction at the moment
and sentiment seems as undecided as it was an hour ago.

There's nothing much in the flow of corporate news that
would provide a game changer even if Sunday's announcement that
Britain's health regulator had started an accelerated review of
AstraZeneca's potential coronavirus vaccine is obviously good to
take.

There's quite a lot of activity in the sector which has
outperformed the market during the COVID-19 crisis but is still
down about 9% year-to-date.

French healthcare group Sanofi made a 308 million euros
takeover offer worth for smaller peer Kiadis while Swiss
drugmaker Roche ROG.S won the European Commission's go-ahead for
its immunotherapy Tecentriq in combination with the older drug
Avastin for liver cancer.

German health technology company Siemens Healthineers also
said it expected sales to rise 5 to 8% in the coming year as
efforts to contain the COVID-19 pandemic allow hospitals to
resume routine care testing activities.

M&A in the battered banking sector is also continuing, as
shown by the announcement late on Friday that state-owned
Budapest Bank and MKB Bank and savings group Takarekbank (MTB)
would form Hungary's second-largest banking group.

In Greece, Alpha Bank said on Monday that it received two
binding bids for the sale of a bad loan portfolio worth about
10.6 billion euros ($12.35 billion).

In Italy, the government is working to support Monte dei
Paschi (MPS) after negotiating with the EU a turnaround process
which must include a merger with a strong peer, Italian Economy
Minister Roberto Gualtieri said on Saturday.

In another sector feeling the full heat of the pandemic,
Ryanair said it expects to fly between 50% and 80% of its
pre-pandemic traffic levels in the summer of 2021.

The Dutch government on Saturday also put on hold its plan
to bail out KLM, the Dutch arm of Air France-KLM after pilots
rejected a wage-freeze until 2025, Finance Minister Wopke
Hoekstra said.

On the bright side, Ocado, the British online supermarket
and technology group which has surfed on te lockdown wave,
raised its EBITDA expectations for 2020 and said it would buy
two robotics companies for a total of $287 million.

(Julien Ponthus and Stefano Rebaudo)

*****

EUROPE ENTERS NOVEMBER ON ITS TOES (0631 GMT)

European stock futures are trading just slightly in positive
territory but there's some pressure on the FTSE 100 derivative
which is currently down 0.3% as England gets ready for a new
lockdown this week.

With ongoing Brexit trade talks, investors seem reluctant to
take the lead from Asia where stocks bounced off one-month lows
thanks to upbeat Chinese manufacturing data.

Rather, the mood seems closer to oil markets where prices
were hit by worries that widening coronavirus lockdowns will
weaken fuel demand with traders bracing for turbulence during
the U.S. presidential election.

Anyhow, while the uncertainty remains high at the beginning
of this first session of November, sentiment should quickly get
its gearing after PMIs are published mid-morning for the main
European economies.

(Julien Ponthus)

*****

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.